For complete access
Get full access to Ratings and recommendations on appliances, cars & trucks, electronic gear, and much more.  today to ConsumerReports.org.
July 2007
send to a friend printable version
Vaccination checklist
The diseases prevented by the 12 childhood vaccines in the table below are bad ones. They can leave you blind, deaf, or paralyzed. They can cause painful infections of the lungs, skin, or bones. They can inflame the brain, turn healthy cells cancerous, or scar the heart. In some cases, they can kill.

Routine vaccination, however, has all but eliminated many of those diseases. For example, in 2005 there were only 66 reported cases of measles in the United States, 1 of polio, and none of diphtheria. In comparison, before vaccination became common some 500,000 people in the U.S. developed measles each year, 176,000 contracted diphtheria, and 16,000 came down with polio. Experts hope that new recommendations for the flu and meningitis vaccines, as well as entirely new vaccines against viruses that contribute to certain other common childhood diseases and even cervical cancer, will prove equally successful. And they caution that failure to vaccinate could lead to a resurgence of some previously controlled diseases. Indeed, recent outbreaks of the mumps and pertussis (whooping cough) may have stemmed in part from declining immunity due to inadequate vaccination. But there's little reason for the average person to avoid being vaccinated, because the potential benefit of vaccination greatly outweighs the potential risks. Those risks include minor reactions such as mild fever or pain at the injection site, severe but rare allergic reactions, and the vaccine-specific side effects listed in the table below.


 
Vaccine Year intro-
duced
Severe consequence of natural disease Percent of children vaccinated age 19-35 months Moderate or severe vaccine side effects Vaccine efficacy (%)
Chicken pox (varicella) 1995 Skin infections, shingles (painful nerve inflammation that develops in adults who had disease as children), encephalitis (brain inflammation) 87.9 Rare 70-90
DTaP, Tdap (for diphtheria, tetanus, and pertussis) 1991 Diphtheria: Paralysis, heart failure, death
Tetanus: Weakened bones, pneumonia, death
Pertussis: Impaired breathing, pneumonia, seizures, death
85.7 Prolonged crying (1 to 9/8000), fever of 104° F or higher (1/3000), convulsions (1/14,000) Diphtheria:
95
Tetanus:
> 99
Pertussis:
80-85
H influenzae B (childhood) 1985 Skin or bone infections, meningitis (inflammation of the lining of brain and spinal cord), pneumonia, systemic blood infection 93.9 Rare 95-100
Hepatitis A 1995 Impaired liver function, death Not available for new recommendations Rare 94-100
Hepatitis B 1981 Impaired liver function, death 92.9 Rare 80-100
HPV (Human papillomavirus) 2006 Genital warts, cervical cancer Not available for new vaccine Appear rare > 99
Influenza, injected (inactivated vaccine), inhaled nasal spray (live vaccine) Shots, 1945; inhaled, 2003 Pneumonia, death Not available for new recommendations Injection: Rare
Nasal spray: nasal congestion (20 to 75/100), headache (2 to 46/100), vomiting (3 to 13/100)
87-90
MMR (for measles, mumps, and rubella) 1967 Measels: Pneumonia, encephalitis, seizures, death
Mumps: Inflamed testicles (in postpubertal males), deafness
Rubella: Blindness and deafness as well as heart defects and retardation in children born to infected mothers
91.5 Fever of 103° F or higher (5 to 15/100 doses), seizure (1/3,000) Measels:
95
Mumps:
95
Rubella:
95
Meningitis 1974 Permanent neurological impairment, loss of limb, death Not available for new recommendations Fever over 100° F (3 to 5/100); headache, vomiting, diarrhea, seizures (3 to 4/100); Guillain-Barre syndrome, or temporary paralysis (rare) >/= 85
Pneumococcal (childhood) 2000 Pneumonia, systemic blood infection, meningitis 53.7 Fever over 100.4° F (15-24/100 doses) 90
Polio (paralytic) 1955 Respiratory failure, post-polio syndrome, paralysis, death 91.7 Vaccine-induced polio (oral vaccine only: 1/2.4 million doses) >/= 99
Rotavirus 2006 Fever, vomiting, dehydration, death Not available for new vaccine Appear rare 74-98
 In general, the more serious the problem, the less common it is.
 After one dose. Reduces severity of symptoms in children who do get disease.
 Tdap approved in 2005 for use as a booster for adolescents age 10-18 (and adults) who have already received full course of DTaP.
 Against infection from four strains of HPV responsible for about 70 percent of cervical cancers and 90 percent of genital warts.
 Inhaled vaccine approved for children age 5 and older.
 Inhaled vaccine has also been associated with 27 percent reduction in risk of ear infections.